SeaStar Medical Stock Scheduled to Reverse Split on Friday, January 2nd (NASDAQ:ICU)

SeaStar Medical Holding Corporation (NASDAQ:ICU)’s stock is scheduled to reverse split on Friday, January 2nd. The 1-10 reverse split was announced on Thursday, December 18th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, December 31st.

SeaStar Medical Price Performance

SeaStar Medical stock opened at $0.24 on Friday. The firm has a market capitalization of $8.83 million, a P/E ratio of -0.15 and a beta of -1.03. The stock has a fifty day moving average price of $0.44 and a two-hundred day moving average price of $0.66. SeaStar Medical has a 52-week low of $0.23 and a 52-week high of $3.07.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. SeaStar Medical had a negative return on equity of 414.50% and a negative net margin of 1,551.08%.The company had revenue of $0.18 million during the quarter, compared to analysts’ expectations of $0.25 million.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SeaStar Medical in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SeaStar Medical currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Armistice Capital LLC bought a new stake in SeaStar Medical during the 1st quarter worth about $1,018,000. Trinity Financial Advisors LLC lifted its position in shares of SeaStar Medical by 233.3% during the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock worth $28,000 after purchasing an additional 35,000 shares in the last quarter. XTX Topco Ltd grew its stake in shares of SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock valued at $26,000 after purchasing an additional 48,674 shares during the last quarter. Finally, Millennium Management LLC acquired a new stake in shares of SeaStar Medical in the third quarter valued at approximately $102,000. Institutional investors and hedge funds own 1.69% of the company’s stock.

SeaStar Medical Company Profile

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.